BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 680459)

  • 1. Differentiation between patients with malignant diseases and non-malignant diseases or healthy donors by changes of fluorescence polarization in the cytoplams of circulating lymphocytes.
    Hashimoto Y; Yamanaka T; Takaku F
    Gan; 1978 Apr; 69(2):145-9. PubMed ID: 680459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders.
    Cercek L; Cercek B; Franklin CI
    Br J Cancer; 1974 May; 29(5):345-52. PubMed ID: 4136566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Response of human lymphocytes to phytohemagglutinin (PHA) as measured by fluorescence polarization technique--differences between malignant conditions and benign or healthy conditions].
    Tenzaki T; Ishiguro T
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):817-25. PubMed ID: 2778375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of lymphocyte stimulation by flow cytometry: differences in cells from patients with and without neoplasia.
    Hartmann W; Sackmann E; Eisert WG; Eisert R; Fliedner TM
    Biomedicine; 1980 Dec; 32(4):185-8. PubMed ID: 7470580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte fluorescence polarization changes after phytohemagglutinin stimulation in the diagnosis of colorectal carcinoma.
    Hocking GR; Rolland JM; Nairn RC; Pihl E; Cuthbertson AM; Hughes ES; Johnson WR
    J Natl Cancer Inst; 1982 Apr; 68(4):579-83. PubMed ID: 6951073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence-polarization changes in mononuclear blood leucocytes after PHA incubation: differences in cells from patients with and without neoplasia.
    Kreutzmann H; Fliedner TM; Galla HJ; Sackmann E
    Br J Cancer; 1978 May; 37(5):797-805. PubMed ID: 656307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of cytoplasmic viscosity by fluorescence polarization in phytohemagglutinin-stimulated and unstimulated human peripheral lymphocytes.
    Hashimoto Y; Shinozaki N
    J Histochem Cytochem; 1988 Jun; 36(6):609-13. PubMed ID: 3367046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Decrease of mitogen stimulation of lymphocytes in rheumatoid arthritis].
    Genth E; Kurze R; Nowak H; Franz K; Brude E; Hartl W
    Z Rheumatol; 1977; 36(5-6):168-79. PubMed ID: 899297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of colon cancer by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
    Merimsky O; Duetsch M; Tirosh R; Wohl I; Weinreb A; Chaitchik S
    Cancer Detect Prev; 1996; 20(4):300-7. PubMed ID: 8818390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the structuredness of cytoplasmic matrix (SCM) in human lymphocytes induced by PHA and cancer basic protein as measured in single cells.
    Cercek L; Cercek B
    Br J Cancer; 1976 May; 33(5):539-43. PubMed ID: 1276032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases.
    Hashimoto Y; Takaku F; Yamanaka T
    Br J Cancer; 1979 Jul; 40(1):156-60. PubMed ID: 454560
    [No Abstract]   [Full Text] [Related]  

  • 12. Response of human lymphocytes to PHA and tumour-associated antigens as detected by fluorescence polarization.
    Balding P; Light PA; Preece AW
    Br J Cancer; 1980 Jan; 41(1):73-85. PubMed ID: 6153900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of lymphocyte fluorescence polarization changes after phytohemagglutinin stimulation in cancer and noncancer conditions.
    Rolland JM; Nairn RC; Nind AP; Pihl E
    J Natl Cancer Inst; 1984 Feb; 72(2):267-73. PubMed ID: 6319791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen-induced changes in the fluorescence polarization of fluorescein in normal human lymphocytes: a membrane event?
    Blakeslee D
    J Natl Cancer Inst; 1979 Aug; 63(2):325-9. PubMed ID: 287826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte fluorescence polarization measurements with the cellscan system: application to the SCM cancer test.
    Deutsch M; Ron I; Weinreb A; Tirosh R; Chaitchik S
    Cytometry; 1996 Feb; 23(2):159-65. PubMed ID: 8742175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro behaviour of lymphocytes from cancer patients and normal individuals cultured with PHA.
    Datta U; Gupta BD; Mahajan MK; Aikat BK
    Indian J Cancer; 1977 Sep; 14(3):211-5. PubMed ID: 924501
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaction of lymphocytes to phytohemagglutinin in vitro in hereditary microspherocytosis.
    Polkowska-Kulesza E; Pluźaska A; Judkiewicz L
    Pol Med Sci Hist Bull (1973); 1976; 15(2):221-4. PubMed ID: 959048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of lymphocytes in a patient with Wiskott-Aldrich syndrome: studies by fluorescence polarization.
    Shiotsuki K; Hirata T; Ota M; Kimura K; Hiyoshi Y; Yamashita F; Yokoyama MM
    J Clin Lab Immunol; 1989 Apr; 28(4):201-5. PubMed ID: 2628582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: A blood-lymphocyte test for cancer?
    Lancet; 1974 Aug; 2(7876):327-8. PubMed ID: 4136185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.